# A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

> **NCT00103454** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 288 (actual)

## Conditions studied

- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** GW685698X

## Key facts

- **NCT ID:** NCT00103454
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2016-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103454, "A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00103454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*